Hebei Weimiao Biology Co., LTD 1
Location
  • Manufacturers of Tetramisole Hydrochloride CAS 20586-74-8 for Pharmaceutical Use

Oktoba . 12, 2024 08:32 Back to list

Manufacturers of Tetramisole Hydrochloride CAS 20586-74-8 for Pharmaceutical Use



Exploring the Manufacturing Landscape of Tetramisole Hydrochloride (CAS 50586-74-8)


Tetramisole hydrochloride, designated by the chemical abstract service (CAS) number 50586-74-8, is a synthetic anthelmintic agent primarily used in veterinary medicine. Its utility in combating parasitic infections has made it a significant compound in the pharmaceutical industry. With the growing demand for effective veterinary medicines, the production of tetramisole hydrochloride has seen a surge, leading to increased activity in manufacturing facilities around the globe.


Understanding Tetramisole Hydrochloride


Tetramisole hydrochloride functions as a powerful deworming agent and is widely utilized in livestock, particularly in sheep and cattle. It operates by inhibiting the enzyme fumarate reductase, disrupting the parasite's energy metabolism, and effectively eradicating nematode infections. Additionally, tetramisole has been noted for its immune-boosting properties, which further enhances its role in veterinary health, making it crucial for maintaining the productivity of livestock.


The Manufacturing Process


The production of tetramisole hydrochloride encompasses several chemical processes, beginning with the synthesis of its active pharmaceutical ingredient (API). Typically, this involves the reaction of specific precursors under controlled conditions to yield the desired compound. Quality control is paramount throughout this process to ensure that the final product is both safe and effective.


Modern manufacturing facilities employ advanced technologies to optimize the yield and purity of tetramisole hydrochloride. This often includes the use of high-performance liquid chromatography (HPLC) for purification and analytical methods to assess the quality of the final product. The integration of automation and process monitoring technologies has streamlined production workflows, ensuring consistency and compliance with regulatory standards.


Global Manufacturing Facilities


cas 5086-74-8 tetramisole hydrochloride factories

cas 5086-74-8 tetramisole hydrochloride factories

The landscape of tetramisole hydrochloride production is diverse, with numerous factories located in various parts of the world. China and India are among the leading producers, capitalizing on their robust chemical manufacturing sectors. These countries have established comprehensive supply chains that facilitate the rapid distribution of veterinary pharmaceuticals globally.


Chinese factories are particularly noteworthy for their capacity to produce bulk quantities of tetramisole hydrochloride, catering to both domestic and international markets. The emphasis on large-scale production has driven down costs, making veterinary medications more accessible. Additionally, Indian manufacturers have emerged as key players, focusing on quality and compliance with international standards, which paves the way for effective entry into global markets.


Regulatory and Quality Considerations


Manufacturers of tetramisole hydrochloride must navigate a rigorous framework of regulatory requirements. This is particularly relevant as the compound is utilized in food-producing animals, where residue limits and safety assessments are critical. Agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe impose stringent guidelines to ensure that the production processes adhere to Good Manufacturing Practices (GMP).


Moreover, manufacturers are increasingly adopting sustainable practices to minimize the environmental impact of production. This includes the responsible management of raw materials and waste, as well as efforts to reduce energy consumption during manufacturing processes.


Conclusion


The manufacturing of tetramisole hydrochloride (CAS 50586-74-8) represents a vital sector within the pharmaceutical industry, contributing significantly to global veterinary health. As the demand for effective deworming agents grows alongside the livestock industry, the capabilities of factories across the globe continue to expand. These facilities not only focus on meeting the needs of the market but also comply with rigorous quality and regulatory standards to ensure that the products delivered are safe, effective, and environmentally responsible. As we look to the future, the ongoing innovation and commitment to excellence in this field will undoubtedly play a crucial role in supporting the health of animal populations worldwide.


Share
Next:

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


swSwahili